Eicosanoids metabolized through LOX distinguish asthma–COPD overlap from COPD by metabolomics study

BACKGROUND AND OBJECTIVE: The prevalence of asthma is greater than 20% in patients previously diagnosed with COPD. Patients with asthma–COPD overlap (ACO) are at risk of rapid progression of disease and severe exacerbations. However, in some patients with ACO, a clear distinction from COPD is very d...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Chron Obstruct Pulmon Dis
Auteurs principaux: Cai, Chuanxu, Bian, Xiqing, Xue, Mingshan, Liu, Xiaoqing, Hu, Haisheng, Wang, Jingxian, Zheng, Song Guo, Sun, Baoqing, Wu, Jian-Lin
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689553/
https://ncbi.nlm.nih.gov/pubmed/31496676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S207023
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires